• Purpose: annual assessment by WHO of global TB burden, progress toward End TB targets, drug resistance, funding, and country profiles.
• Key indicators to track:
  • Global and regional TB incidence and mortality
  • TB/HIV co-infection rates
  • MDR-TB/XDR-TB prevalence and treatment outcomes
  • Treatment success rate and loss to follow-up
  • Funding gaps and financing for TB programs
• Policy signals:
  • Progress against End TB Strategy milestones
  • Innovative detection/treatment approaches (rapid diagnostics, shorter regimens, community-based interventions)
  • National TB programs alignment (e.g., India’s NTEP/Nikshay, financing, private sector engagement)

2. India-focused takeaways (India-specific data to extract for Mains)

• Position in global TB burden and trend: incidence and mortality trajectory; progress toward End TB targets within India.
• TB/HIV co-infection: proportion of TB patients co-infected and integration with HIV programs.
• Drug-resistant TB: burden of MDR-TB/XDR-TB, enrollment in program, treatment success rates.
• National program milestones: updated targets (End TB by 2025/2030), diagnostic/treatment expansion, private sector engagement, community DOTS, and Nikshay platform data.
• Financing and policy actions: domestic funding levels, procurement of drugs, new regimens, laboratory capacity, and social determinants addressed (malnutrition, housing, urban-rural disparities).
• Challenges highlighted: late presentation, adherence, stigma, TB notification gaps, data quality, and private sector reporting.
• International support and collaboration: role of WHO, Stop TB Partnership, Global Fund contributions, and India’s role in regional/global targets.
• Potential UPSC Mains questions (Essay, GS paper 2/3)

• Discuss the progress and remaining challenges in India’s fight against TB in light of the Global TB Report 2025.
• Analyze how global TB targets influence national health policy, with reference to End TB strategy and India’s NTEP.
• Evaluate the role of innovations (short-course regimens, rapid diagnostics, digital notification) in accelerating TB elimination; assess applicability in India’s public health system.
• Critically assess the funding landscape for TB programs and its implications for universal health coverage.
• Compare TB control strategies in high-burden countries and extract best practices for India.

Mains answer structure (example outline)

• Introduction: Brief on TB burden globally and in India; importance of the Global TB Report 2025.
• Global snapshot: key global trends (incidence, mortality, MDR-TB, funding); End TB targets and remaining gaps.
• India-specific analysis: burden, progress under NTEP, major achievements, gaps, and policy responses.
• Policy evaluation: effectiveness of current strategies (early detection, DOTS, BCG, preventive therapy, private sector engagement); integration with HIV program; social determinants.
• Challenges and risks: data quality, urban slums, migrant populations, stigma, supply chain, and accessibility.
• Way forward: recommended actions—scale-up diagnostics and treatment, strengthen data systems (digital), public-private mix, community engagement, financing, and monitoring.
• Conclusion: synthesis and alignment with global targets.